NCT03902184Phase 2Completed

IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

Study sponsor: Innate Pharma

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-01-08Actual
Enrollment · participants170Actual
Source updated2026-04-29Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Primary completion date changed

Before: 31 Oct 2023. After: 8 Jan 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview